Meet the 2022 Endocrine Society Laureates: Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS

Ho_Laureate2022

Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS 

Outstanding Scholarly Physician Award

Ken K.Y. Ho, MD, FRACP, FRCP, FAHMS, is emeritus professor at the Garvan Institute, University of New South Wales, and honorary consultant endocrinologist, St. Vincent’s Hospital in Sydney, Australia. 

As a globally recognized pituitary medicine expert and a leader in academic clinical endocrinology, he’s developed therapeutic guidelines and advocated for regulatory agency decisions geared toward improving patient outcomes. He established a gold-standard diagnostic test for growth hormone (GH) deficiency and developed standards for use of GH replacement therapy in adults. 

He’s published over 250 peer-reviewed studies that directly impact clinical practice and is currently an associate editor for the Journal of the Endocrine Society and a member of the Society’s Nominating Committee. 

How has the Endocrine Society supported your professional development/career journey?

The Endocrine Society has been integral to my career development in providing a culture of academic excellence for clinicians and a governance structure of engagement and inclusion.

As a Laureate Award recipient, do you have any advice for those just beginning their careers?

Follow your passion guided by the signposts for learning and for achieving clinical and scholarly excellence from a mentor and your Society.

You may also like

  • Hoshino Wins Wayne Bardin International Travel Award

    The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne…

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

Find more in